Seattle, Washington, October 15, 2015
Genomics England has chosen the LabKey Server open source platform to provide its integrated data management solution. Genomics England will work with LabKey to design and develop a solution that will integrate
... [More]
and securely share complex clinical and genomic data for the 100,000 Genomes Project.
The 100,000 Genomes Project aims to sequence 100,000 whole genomes from approximately 70,000 people. Participants are NHS patients in the UK with certain types of cancer or with rare disease, as well as their families. The initiative will bring together an unprecedented depth of clinical and genomic information to improve prediction and prevention of disease, spur the development of new diagnostics, and support personalization of medical treatments based on genotypes. This is currently the largest national sequencing project of its kind in the world.
The LabKey solution will facilitate aggregation, review and integration of phenotype and genotype information across contributing labs, clinical sites and repositories. It will also enable review, reporting and analysis of this information by both clinicians and researchers, ensure protection of patient privacy, and support data de-identification and knowledge sharing.
Jim Davies, Chief Technology Officer of Genomics England explains, “By partnering with LabKey, we bring on board an excellent software platform and a technical team whose expertise in developing enterprise solutions for biomedical research and healthcare will significantly accelerate our efforts.
“We are excited to build on the rich foundation of LabKey Server. It is unique among tools in this field for its quality, extensibility, and reporting and analytical capabilities.”
“We see enormous potential for the work of Genomics England to benefit both patient care and research. We are proud and excited to be part of this innovative initiative,” adds Michael Gersch, CEO of LabKey Software.
“Building on the LabKey Server platform lets Genomics England leverage years of development with hundreds of research institutions and focus investment on incremental functionality needed beyond this proven base.”
About Genomics England
Genomics England is a company owned by the Department of Health and was set up to deliver the 100,000 Genomes Project. This flagship project will sequence 100,000 whole genomes from NHS patients and their families by 2017.
Genomics England has four main aims:
to bring benefit to patients
to create an ethical and transparent programme based on consent
to enable new scientific discovery and medical insights
to kickstart the development of a UK genomics industry
The project is focusing on patients with rare diseases, and their families, as well as patients with common cancers.
About LabKey Software
LabKey Software develops secure data solutions that help biomedical organizations integrate, analyze and share complex research and clinical information, opening doors to new modes of insight, healthcare and collaboration. LabKey solutions build on the LabKey Server open source platform, so users benefit from more than a decade of past investment. LabKey Software originated at the Fred Hutchinson Cancer Research Center and has offices in Seattle and San Diego. [Less]
|
Seattle, Washington, October 15, 2015
Genomics England has chosen the LabKey Server open source platform to provide its integrated data management solution. Genomics England will work with LabKey to design and develop a solution that will integrate
... [More]
and securely share complex clinical and genomic data for the 100,000 Genomes Project.
The 100,000 Genomes Project aims to sequence 100,000 whole genomes from approximately 70,000 people. Participants are NHS patients in the UK with certain types of cancer or with rare disease, as well as their families. The initiative will bring together an unprecedented depth of clinical and genomic information to improve prediction and prevention of disease, spur the development of new diagnostics, and support personalization of medical treatments based on genotypes. This is currently the largest national sequencing project of its kind in the world.
The LabKey solution will facilitate aggregation, review and integration of phenotype and genotype information across contributing labs, clinical sites and repositories. It will also enable review, reporting and analysis of this information by both clinicians and researchers, ensure protection of patient privacy, and support data de-identification and knowledge sharing.
Jim Davies, Chief Technology Officer of Genomics England explains, “By partnering with LabKey, we bring on board an excellent software platform and a technical team whose expertise in developing enterprise solutions for biomedical research and healthcare will significantly accelerate our efforts.
“We are excited to build on the rich foundation of LabKey Server. It is unique among tools in this field for its quality, extensibility, and reporting and analytical capabilities.”
“We see enormous potential for the work of Genomics England to benefit both patient care and research. We are proud and excited to be part of this innovative initiative,” adds Michael Gersch, CEO of LabKey Software.
“Building on the LabKey Server platform lets Genomics England leverage years of development with hundreds of research institutions and focus investment on incremental functionality needed beyond this proven base.”
About Genomics England
Genomics England is a company owned by the Department of Health and was set up to deliver the 100,000 Genomes Project. This flagship project will sequence 100,000 whole genomes from NHS patients and their families by 2017.
Genomics England has four main aims:
to bring benefit to patients
to create an ethical and transparent programme based on consent
to enable new scientific discovery and medical insights
to kickstart the development of a UK genomics industry
The project is focusing on patients with rare diseases, and their families, as well as patients with common cancers.
About LabKey Software
LabKey Software develops secure data solutions that help biomedical organizations integrate, analyze and share complex research and clinical information, opening doors to new modes of insight, healthcare and collaboration. LabKey solutions build on the LabKey Server open source platform, so users benefit from more than a decade of past investment. LabKey Software originated at the Fred Hutchinson Cancer Research Center and has offices in Seattle and San Diego.
[Less]
|
Dear LabKey Community,
We are pleased to share with you our new LabKey Server Editions, the next iteration of LabKey Service Plans, and also to provide a brief update on the upcoming LabKey User Conference.
... [More]
Our approach reflects our team’s deep commitment to providing life science and healthcare groups with open, professional-grade, cost-effective solutions. We offer a balance of free and premium products to help us ensure a strong, sustainable platform for all.
LabKey Server Editions
Community Edition - Our free edition provides a robust, open source platform that LabKey Software continues to enhance, develop and maintain. We also continue to facilitate the community support forums and provide free, public documentation.
Premium Editions - Premium Editions include professional support, training, and consulting. They also include access to a growing list of features that are only available to subscribers.
Professional - Replaces our Standard Service Plan. Intended for researchers who want to optimize their use of LabKey Server, but do not need deep integration with other systems or extensive customization.
Professional Plus - Replaces our Platform Service Plan. Adds deeper technical support, including system architecture and design advice, developer training and support across all aspects of developing LabKey Server applications.
Enterprise - Designed for teams that need to support clinical data integration at large scale, potentially including regulatory compliance.
LabKey Software is investing in premium features to benefit the user base and extend the value of the LabKey platform. Source code for premium features is available to subscribers to keep and modify for their own use in perpetuity, without the right to sell or redistribute the code to others.
For current customers, there is no change to your engagement with LabKey and you retain access to the same features and services you have today. Going forward, access to premium features depends on your LabKey Premium Edition subscription. We continue to offer professional software development of custom features and design services to all clients, regardless of the LabKey Server Premium Edition they choose.
In addition, the LabKey team is developing new products to extend the value of LabKey Server and grow our user community. We recently announced our partnership with Just Biotherapeutics to develop a new Biologics Registration product to help R&D teams produce more effective and affordable biotherapeutics.
LabKey User Conference
The LabKey team and our presenters are looking forward to next week’s sold out LabKey User Conference and Workshop 2015. The sessions will provide an engaging opportunity to learn from each other and we appreciate that so many people are able to attend.
Thank You!
This is an exciting time for us. The LabKey team is growing and we remain thankful to our many partners with whom we have worked through the years. These announced changes allow us to accelerate the enhancement and expansion of LabKey Server.
Please contact me or another member of the team to discuss this announcement or areas where LabKey can help with your informatics goals.
Thanks,
Michael
Michael Gersch
CEO
LabKey Software
206.489.2578
[email protected]
[Less]
|
Dear LabKey Community,
We are pleased to share with you our new LabKey Server Editions, the next iteration of LabKey Service Plans, and also to provide a brief update on the upcoming LabKey User Conference.
... [More]
Our approach reflects our team’s deep commitment to providing life science and healthcare groups with open, professional-grade, cost-effective solutions. We offer a balance of free and premium products to help us ensure a strong, sustainable platform for all.
LabKey Server Editions
Community Edition - Our free edition provides a robust, open source platform that LabKey Software continues to enhance, develop and maintain. We also continue to facilitate the community support forums and provide free, public documentation.
Premium Editions - Premium Editions include professional support, training, and consulting. They also include access to a growing list of features that are only available to subscribers.
Professional - Replaces our Standard Service Plan. Intended for researchers who want to optimize their use of LabKey Server, but do not need deep integration with other systems or extensive customization.
Professional Plus - Replaces our Platform Service Plan. Adds deeper technical support, including system architecture and design advice, developer training and support across all aspects of developing LabKey Server applications.
Enterprise - Designed for teams that need to support clinical data integration at large scale, potentially including regulatory compliance.
LabKey Software is investing in premium features to benefit the user base and extend the value of the LabKey platform. Source code for premium features is available to subscribers to keep and modify for their own use in perpetuity, without the right to sell or redistribute the code to others.
For current customers, there is no change to your engagement with LabKey and you retain access to the same features and services you have today. Going forward, access to premium features depends on your LabKey Premium Edition subscription. We continue to offer professional software development of custom features and design services to all clients, regardless of the LabKey Server Premium Edition they choose.
In addition, the LabKey team is developing new products to extend the value of LabKey Server and grow our user community. We recently announced our partnership with Just Biotherapeutics to develop a new Biologics Registration product to help R&D teams produce more effective and affordable biotherapeutics.
LabKey User Conference
The LabKey team and our presenters are looking forward to next week’s sold out LabKey User Conference and Workshop 2015. The sessions will provide an engaging opportunity to learn from each other and we appreciate that so many people are able to attend.
Thank You!
This is an exciting time for us. The LabKey team is growing and we remain thankful to our many partners with whom we have worked through the years. These announced changes allow us to accelerate the enhancement and expansion of LabKey Server.
Please contact me or another member of the team to discuss this announcement or areas where LabKey can help with your informatics goals.
Thanks,
Michael
Michael Gersch
CEO
LabKey Software
206.489.2578
[email protected]
[Less]
|
Wednesday, September 30th, 10:00 am PDT (60 Minutes)
LabKey Software and De Novo Software have worked together to provide direct export capabilities from FCS Express 5 Flow Cytometry to LabKey Server. The collaboration allows high-volume flow
... [More]
cytometry users to leverage not only the report generation and analysis capabilities of FCS Express, but also the sophisticated, web-based data environment provided by LabKey Server, including flexible tools for quality control and workflow customization. Join the LabKey Software and De Novo Software teams in this webinar to learn how to export from FCS Express to the LabKey Server and get the most our of your data.
LabKey presenter: Program Manager Bernard Lee
Register
[Less]
|
Wednesday, September 30th, 10:00 am PDT (60 Minutes)
LabKey Software and De Novo Software have worked together to provide direct export capabilities from FCS Express 5 Flow Cytometry to LabKey Server. The collaboration allows high-volume flow
... [More]
cytometry users to leverage not only the report generation and analysis capabilities of FCS Express, but also the sophisticated, web-based data environment provided by LabKey Server, including flexible tools for quality control and workflow customization. Join the LabKey Software and De Novo Software teams in this webinar to learn how to export from FCS Express to the LabKey Server and get the most our of your data.
LabKey presenter: Program Manager Bernard Lee
Register [Less]
|
New software product targets biotherapeutic research and development
Seattle, Washington, September 02, 2015
LabKey Software and Just Biotherapeutics, Inc. have signed a multi-year agreement to develop a new software product that helps
... [More]
biotechnology R&D teams produce more effective and affordable biotherapeutics by optimizing development processes. [Less]
|
New software product targets biotherapeutic research and development
Seattle, Washington, September 02, 2015
LabKey Software and Just Biotherapeutics, Inc. have signed a multi-year agreement to develop a new software product that helps
... [More]
biotechnology R&D teams produce more effective and affordable biotherapeutics by optimizing development processes. [Less]
|
|
We're delighted to announce the release of LabKey Server v15.2 and share other exciting community news.
|
|
We're delighted to announce the release of LabKey Server v15.2 and share other exciting community news.
|
